Odyssean Portfolio Expansion
Odyssean LLC significantly expands its equity investments across five publicly traded companies during the second quarter.
Anonymous
Key Points
1
Institutional investors and hedge funds held 73.92% of First Merchants Corporation’s stock. The company’s shares opened at $42.06, with a 12-month range of $34.66 to $45.33; it also declared a quarterly dividend of $0.37 per share, equivalent to a 3.5% annualized yield.
2
Madison Square Garden had 68.94% institutional ownership, while analysts raised their price targets: JPMorgan Chase lifted its target to $485 and Guggenheim raised its target to $584, with both firms maintaining bullish ratings.
3
ADMA Biologics’ new Odyssean position represented 0.06% of the biotechnology company at the end of the quarter, and institutional investors and hedge funds collectively owned 75.68% of its stock.
4
Freedom Holding was only 1.26% institutionally owned, despite additional purchases by several firms; Wedbush set a $180 price target, while KeyCorp reiterated a market-perform rating.
Odyssean LLC aggressively expanded its stock portfolio in the second quarter, boosting positions across five publicly traded companies with total purchases worth millions of dollars WatchlistNews. The investment firm increased its stake in Freedom Holding by 87.7% to 21,511 shares valued at $2.8 million and raised its Madison Square Garden holding by 64.4% to 7,728 shares worth $3.1 million WatchlistNews.
Beyond these major increases, Odyssean more than doubled its First Merchants position by 125.6% to 30,458 shares valued at $1.3 million TickerReport. The firm also jumped into Columbus McKinnon with a 432% stake increase to 73,022 shares worth $1.1 million and launched a new position in ADMA Biologics with 124,498 shares valued at roughly $1 million TickerReport.
Madison Square Garden Sees Analyst Upgrades
Madison Square Garden attracted bullish new analyst attention as Odyssean expanded its stake. JPMorgan Chase lifted its price target to $485, while Guggenheim raised its target to $584 WatchlistNews. Both firms maintained buy ratings on the entertainment company, which has 68.94% institutional ownership WatchlistNews.
First Merchants Offers Dividend Income Stream
First Merchants Corporation, where Odyssean more than doubled its holdings, offers shareholders steady income. The company declared a quarterly dividend of $0.37 per share, which translates to a 3.5% annualized yield WatchlistNews. Institutional investors and hedge funds own 73.92% of First Merchants, with shares trading in a 12-month range of $34.66 to $45.33 WatchlistNews.
ADMA Biologics Enters Odyssean's Portfolio
Odyssean's newest investment is a 124,498-share stake in biotech firm ADMA Biologics, worth approximately $1 million at quarter-end WatchlistNews. Despite the fresh position, Odyssean's holding represents just 0.06% of the company WatchlistNews. Institutional investors collectively own 75.68% of ADMA Biologics WatchlistNews.
Freedom Holding Remains Thinly Institutionalized
Freedom Holding presents a unique profile among Odyssean's expanded holdings: the company has only 1.26% institutional ownership despite growing investor interest TickerReport. Wedbush set a $180 price target on the stock, while KeyCorp maintained a market-perform rating WatchlistNews. Odyssean's 87.7% increase in Freedom Holding puts the firm among growing institutional holders TickerReport.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
12
Articles
8
Reach
20
Topics
A
AnonymousAuthor
